Source: Natural News
Over 100,000 patients are suing Johnson & Johnson and their pharmaceutical division Janssen for damages resulting from the use of the drug Risperdal. The lawsuits stem from evidence that taking the drug has caused male patients to suffer from the condition gynecomastia, which causes not only significant weight gain but also the development of breasts. There is also substantial evidence that the company was aware of these adverse effects and did not properly warn the public.
Risperdal has been prescribed by doctors to treat schizophrenia in adults and adolescents, bipolar disorder in adults and children between the ages of 10-17, attention deficit hyperactivity disorder (ADHD) sufferers of various ages, and for dementia-related psychosis in elderly adults. The FDA approved the drug in 1993 for adults, but it wasn’t until 2006 that it received approval to sell the medication to children. Evidence has shown that J&J was…
View original post 507 more words